Work

The estimated cost of MK-8527 produced at scale for once-monthly oral HIV pre-exposure prophylaxis in low- and middle-income countries

Year: 2026

Type: article

Source: AIDS

DOI: 10.1097/qad.0000000000004487

Authors: Samuel Cross, Jacob Levi, Francois Venter, Andrew Hill

Institutions: Health New Zealand, Royal Free London NHS Foundation Trust, The Royal Free Hospital, University of the Witwatersrand, University of Liverpool

Language: English

Topic: Pharmaceutical Economics and Policy

Subfield: Economics and Econometrics

Field: Economics, Econometrics and Finance

Domain: Social Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W7148046611

FWCI: 14.3

Cites: 12

Cited by: 2

Related to: